BPCE 6.125% until 05/24/2029 News - BPCFZ

U.S. HOT STOCK FUTURES: HOT STOCKS to WATCH

Among the companies with shares expected to actively trade in Monday's session are DSW Inc. (DSW), Infinity Pharmaceuticals Inc. (INFI) and Steel...

U.S. HOT STOCK FUTURES: HOT STOCKS to WATCH

Among the companies with shares expected to actively trade in Monday's session are Steel Dynamics Inc. (STLD) and K-V Pharmaceuticals Co. (KVA...

Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical Company

Glancy Binkow & Goldberg LLP announces that all persons or entities who purchased the securities of K-V Pharmaceutical Company...

Law Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical Company

Law Offices of Howard G. Smith, representing investors of K-V Pharmaceutical Company (“K-V" or the “Company”) (NYSE:KV-A...

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical Company

Notice is hereby given that Glancy Binkow & Goldberg LLP has filed a class action lawsuit in the United States District Court for...

Faruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical Company

Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights, consumer rights and enforcement of federal antitrust...

The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical Company

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the...

Law Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical Company

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of purchasers of the common stock...

K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference Call

K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference Call PR Newswire ST. LOUIS, June 13, 2011...

UPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid Outcry

(Adds details about March of Dimes criticism, lawmaker reaction and background throughout.) By Peter Loftus Of DOW JONES NEWSWIRES K-V...

K-V Pharma Slashes Prices Of Preterm Labor Drug After FDA Move

K-V Pharmaceutical Co. (KVA, KVB) slashed the list price of a drug to help prevent preterm births, following the Food and Drug Administration's...

Religious Groups Urge Drug Makers To Ease Up On Price Hikes

By Peter Loftus Of DOW JONES NEWSWIRES Some religious groups are pressing major drug companies including Pfizer Inc. (PFE) and Johnson &...

UPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug

(Updates with statement from K-V in the seventh through ninth paragraphs. Adds new stock quote in the fifth paragraph.) DOW JONES NEWSWIRES Shares...

K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug

Shares of K-V Pharmaceutical Co. (KVA, KVB) dropped after the Food and Drug Administration said it won't take action against pharmacies that...

K-V Pharmaceutical Company Announces $200 Million Private Debt Offering

K-V Pharmaceutical Company Announces $200 Million Private Debt Offering PR Newswire ST. LOUIS, March 1, 2011 ST. LOUIS, March 1, 2011...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

BPCE 6.125% until 05/24/2029 (BPCFZ)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

BPCFZ News

U.S. HOT STOCK FUTURES: HOT STOCKS to WATCH

U.S. HOT STOCK FUTURES: HOT STOCKS to WATCH

Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical Company

Law Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical Company

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical Company

Faruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical Company

The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical Company

Law Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical Company

K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference Call

UPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid Outcry

K-V Pharma Slashes Prices Of Preterm Labor Drug After FDA Move

Religious Groups Urge Drug Makers To Ease Up On Price Hikes

UPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug

K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug

K-V Pharmaceutical Company Announces $200 Million Private Debt Offering

BPCFZ Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

BPCE 6.125% until 05/24/2029 (BPCFZ) News

BPCE 6.125% until 05/24/2029 (BPCFZ)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

BPCFZ News

U.S. HOT STOCK FUTURES: HOT STOCKS to WATCH

U.S. HOT STOCK FUTURES: HOT STOCKS to WATCH

Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical Company

Law Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical Company

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical Company

Faruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical Company

The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical Company

Law Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical Company

K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference Call

UPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid Outcry

K-V Pharma Slashes Prices Of Preterm Labor Drug After FDA Move

Religious Groups Urge Drug Makers To Ease Up On Price Hikes

UPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug

K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug

K-V Pharmaceutical Company Announces $200 Million Private Debt Offering

BPCFZ Discussion

Your Recent History